4 terminated. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 3 | Terminated 3 |
Follow AEG 35156: new trials by email Literature Review of AEG 35156 trials Research Report on AEG 35156
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen AEG35156 - Leukemia | Phase 2 | Terminated | Aegera Therapeutics | 60 | 2009-11-01 | 2011-07-13 |
| A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer AEG35156 - Human Mammary Carcinoma | Phase 1 / Phase 2 | Terminated | Aegera Therapeutics | 61 | 2007-11-01 | 2009-12-02 |
| A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer AEG35156 - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Terminated | Aegera Therapeutics | 54 | 2007-09-01 | 2009-07-30 |
| A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer AEG35156 - Carcinoma, Pancreas | Phase 1 / Phase 2 | Terminated | Aegera Therapeutics | 48 | 2007-09-01 | 2009-12-01 |
Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Leukemia (1) · Leukemia, Promyelocytic, Acute (1)
United States (4) · Canada (1) · Germany (1)
Jacques Jolivet, MD, FACP (3) · Aaron Schimmer, MD (1) · Daniel D Von Hoff, MD, FACP (1) · David M Loesch, MD (1) · Robert M Jotte, MD (1)
2009 (1)